ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
68 075,65
0,52%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Encysive Pharmaceuticals (MM) (ENCY)

  7. Encysive Pharmaceuticals (MM) (ENCY) Actualités

ENCY

Encysive Pharmaceuticals (MM) (ENCY)

Encysive Pharmaceuticals (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ENCY
DateHeureSourceTitreSymboleSociété
10/06/200815h48Edgar (US Regulatory)Encysive Pharmaceuticals Inc- (25-NSE)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
10/06/200813h00Business WirePfizer Completes Acquisition of Encysive Pharmaceuticals Inc.NASDAQ:ENCYEncysive Pharmaceuticals (MM)
12/05/200823h15Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
12/05/200820h24Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Schedule 13GNASDAQ:ENCYEncysive Pharmaceuticals (MM)
30/04/200823h31Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Tender offer statement by Issuer (SC TO-I)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
16/04/200823h31Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Information Statement - Merger or Acquisition (preliminary) (PREM14C)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
16/04/200822h50Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
15/04/200823h30Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
15/04/200822h27Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
11/04/200823h21Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Statement of Beneficial Ownership (SC 13D)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
11/04/200821h58Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
08/04/200814h10Business WirePfizer Extends Subsequent Offering Period of Tender Offer for Shares of Encysive PharmaceuticalsNASDAQ:ENCYEncysive Pharmaceuticals (MM)
08/04/200800h28Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
08/04/200800h26Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Statement of Beneficial Ownership (3/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
07/04/200823h02Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
07/04/200820h04Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
03/04/200822h46PR Newswire (US)QED International Associates Announces Changes to the HealthShares(TM) Respiratory Pulmonary Index and the HealthShares(TM) CompNASDAQ:ENCYEncysive Pharmaceuticals (MM)
27/03/200822h05Business WirePfizer Obtains Clearance from Federal Cartel Office of Germany for Acquisition of All Outstanding Shares of Encysive PharmaceutiNASDAQ:ENCYEncysive Pharmaceuticals (MM)
27/03/200813h00Business WirePfizer Clears U.S. Antitrust Review for Acquisition of All Outstanding Shares of Encysive Pharmaceuticals Inc.NASDAQ:ENCYEncysive Pharmaceuticals (MM)
27/03/200811h01Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Annual Report (10-K/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
17/03/200822h17Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
04/03/200823h01Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
04/03/200822h58Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Tender offer statement by Third Party (SC TO-T)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
04/03/200822h56Business WirePfizer Announces Commencement of Tender Offer for All Outstanding Shares of Encysive Pharmaceuticals Inc.NASDAQ:ENCYEncysive Pharmaceuticals (MM)
21/02/200815h48PR Newswire (US)BeaconEquity.com Issues TraderNotes on MTTG, ENCY, RIMM, DRYS, SPWRNASDAQ:ENCYEncysive Pharmaceuticals (MM)
20/02/200815h14Business WirePfizer to Acquire Encysive PharmaceuticalsNASDAQ:ENCYEncysive Pharmaceuticals (MM)
14/02/200818h08Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Schedule 13G (SC 13G/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
15/01/200823h03Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Amended Current report filing (8-K/A)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
24/09/200723h14Edgar (US Regulatory)Encysive Pharmaceuticals Inc (Other) (8-K)NASDAQ:ENCYEncysive Pharmaceuticals (MM)
06/09/200712h02Edgar (US Regulatory)Encysive Pharmaceuticals Inc - Current report filingNASDAQ:ENCYEncysive Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:ENCY

Dernières Valeurs Consultées

EU
AF
Air FranceKLM
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
COIN
ETHUSD
Ethereum
EU
GLE
Societe Generale
EU
SGO
Cie de SaintGobain
NASDAQ
AAPL
Apple
EU
AI
Air Liquide
EU
EN
Bouygues
COIN
BTCUSD
Bitcoin
EU
BEL20
Bel 20
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
NYSE
MRK
Merck
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés